lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Cimduo]
RxNorm concept 2003255, branded drug (sbd). Prescribable name: Cimduo 300 MG / 300 MG Oral Tablet.
- RxCUI
- 2003255
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2003255 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
3TC 300 MG / Tenofovir disoproxil fumarate 300 MG Oral Tablet [Cimduo]; Cimduo (lamiVUDine 300 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG)) Oral Tablet; Cimduo (lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG)) Oral Tablet; lamiVUDine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Cimduo]
Related concepts
- lamivudine 300 MG (SCDC, consists of)
- tenofovir disoproxil fumarate 300 MG (SCDC, consists of)
- lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG [Cimduo] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Cimduo (BN, has ingredient)
- lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2003255 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2003255 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2003255. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.